This site uses cookies to improve user experience by collecting data. By continuing to use this website, you agree to the use of cookies and similar technologies as described in our 隱私政策.
確認
合作發展次世代細胞療法

育世博股份有限公司積極尋找有興趣合作的夥伴,共同開發創新且高效力的細胞療法,治療癌症以及其他未滿足之醫療需求。我們相信,透過抗體細胞結合技術(ACC)直接將抗體結合至異體細胞可大幅推動細胞治療領域的進展。此外,我們專有的γδ2T細胞表現CD16,賦予細胞具有抗體依賴型細胞毒殺作用(ADCC)之活性,從而提高臨床上使用的單株抗體(mAb)之療效。

Join us if you share our vision

Acepodia is committed to delivering innovative and highly effective cell therapies for patients with cancer.
To discuss partnering with Acepodia, please contact: info@acepodiabio.com